Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Perioperative Complications in Minimally Invasive Sacrocolpopexy Versus Transvaginal Mesh in the Management of Pelvic Organ Prolapse

Analysis of a National Multi-institutional Dataset

Kisby, Cassandra K., MD*; Occhino, John A., MD, MS*; Bews, Katherine A., MS; Habermann, Elizabeth B., PhD; Linder, Brian J., MD, MS*‡

Female Pelvic Medicine & Reconstructive Surgery: May 13, 2019 - Volume Publish Ahead of Print - Issue - p
doi: 10.1097/SPV.0000000000000738
Original Article: PDF Only
Buy
SDC
PAP

Objectives The objective of this study was to evaluate perioperative complications in women who underwent minimally invasive sacrocolpopexy (MISC) versus mesh-augmented vaginal repair (vaginal mesh) for pelvic organ prolapse.

Methods We identified patients undergoing MISC and vaginal mesh via Current Procedural Terminology codes from the American College of Surgeons National Surgical Quality Improvement Program database from 2005 to 2016. Those undergoing concomitant hysterectomy were excluded. Univariate analyses were performed to compare baseline characteristics and 30-day complications. Multivariable logistic regression models were constructed to assess the association between surgical approach and complications, prolonged hospitalization, reoperation, and blood transfusion. A multivariable Cox proportional hazard model was used to evaluate hospital readmission.

Results A total of 5722 patients were identified (2573 MISC [45%], 3149 vaginal mesh [55%]). Those undergoing MISC repairs had a significantly lower rate of urinary tract infection (3.1 vs 4.2%; P = 0.03) and blood transfusion (0.5 vs 1.4%; P < 0.001). There was no difference in reoperation rate (1.3 vs 1.6%; P = 0.35). Multivariable analysis showed no significant association of MISC with overall (odds ratio [OR], 0.91; P = 0.44), major (OR, 1.30; P = 0.31), or minor complication (OR, 0.85; P = 0.26). There were lower odds of receiving a blood transfusion (OR, 0.44; P = 0.02) and higher odds of prolonged hospitalization (>2 days; OR, 1.47; P = 0.003) for the MISC group. There was no difference in reoperation (OR, 0.79; P = 0.38) or hospital readmissions (hazard ratio, 1.25, P = 0.32).

Conclusions Minimally invasive sacrocolpopexy was associated with a lower rate of blood transfusion than transvaginal mesh placement. There was no significant difference in 30-day complication rates, reoperation, or readmission between these prolapse procedures when performed without concomitant hysterectomy.

From the *Division of Urogynecology, Mayo Clinic;

Surgical Outcomes Program, Mayo Clinic Kern Center for the Science of Health Care Delivery; and

Department of Urology, Mayo Clinic, Rochester, MN.

Correspondence: Cassandra K. Kisby, MD, Division of Urogynecology, Mayo Clinic, Eisenberg Bldg, LO-71, 200 First St SW, Rochester, MN 55905. E-mail: Kisby.cassandra@mayo.edu.

The authors have declared they have no conflicts of interest.

Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.fpmrs.net).

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.